Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENTINEL: Toremifene and Melatonin for Early COVID-19
NCT04531748Phase 2Withdrawn
- Start
- Dec 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of toremifene in coronavirus disease 2019 (COVID-19). Planned start Dec 2021; status: withdrawn.
02
Drugs
toremifene
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04531748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04531748.